{"id":1031753,"title":"DSEN Abstract: Prescription patterns of ranitidine, nizatidine, famotidine, and cimetidine in Canada - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-13","captureTimestamp":"2026-02-13T20:20:10.914000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52735.html?wbdisable=true","snippet":"DSEN Abstract Prescription patterns of ranitidine, nizatidine, famotidine, and cimetidine in Canada In 2019, some batches of ranitidine, a readily available histamine H-2 receptor antagonist that counteracts stomach acid, contained an impurity called N-nitrosodimethylamine…","rawSnapshotUrl":"/api/snapshots/raw/1031753","browseUrl":"https://replay.healtharchive.ca/job-8/20260213202010/https://cihr-irsc.gc.ca/e/52735.html?wbdisable=true#ha_snapshot=1031753","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}